Genetic Technologies Ltd (GENE)

1.168
-0.047(-3.88%)
After Hours
1.140
-0.028(-2.389%)
- Real-time Data
  • Volume:
    16,619
  • Day's Range:
    1.168 - 1.247
  • 52 wk Range:
    0.950 - 3.230

GENE Overview

Prev. Close
1.215
Day's Range
1.168-1.247
Revenue
4.02M
Open
1.2
52 wk Range
0.95-3.23
EPS
-0.001
Volume
16,619
Market Cap
23.65M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
76,870
P/E Ratio
-5.17
Beta
1.28
1-Year Change
-63.39%
Shares Outstanding
9,233,965,143
Next Earnings Date
-
What is your sentiment on Genetic Technologies?
or
Market is currently closed. Voting is open during market hours.

Genetic Technologies Ltd News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Genetic Technologies Ltd Analysis

Genetic Technologies Ltd Company Profile

Genetic Technologies Ltd Company Profile

Genetic Technologies Limited, a molecular diagnostics company, provides predictive genetic testing and risk assessment tools to help physicians manage people’s health in the United States, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. It operates in two segments, EasyDNA and GeneType/Corporate. The company offers BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/gynecologists and breast cancer risk assessment specialists, such as breast surgeons. In addition, the company offers various cancer risk assessment tests under the GeneType for Colorectal Cancer and GeneType for Breast Cancer brand names; and develops other risk assessment tests across a range of diseases, which include colorectal cancer, ovarian cancer, prostate cancer, coronary artery, and type 2 diabetes. Further, it offers genetic testing services, including medical, animal, forensic, and plant testing. The company has research and collaboration agreements with the University of Melbourne, Translational Genomics Research Institute, Memorial Sloan Kettering New York Cambridge University, the Ohio State University, and Shivom. Genetic Technologies Limited was incorporated in 1987 and is headquartered in Fitzroy, Australia.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsSellSellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
  • Trading halt on ASX for GTG (the underlying stock of GENE) today - waiting for announcement regardig the Covid-19 risk test.
    0
    • Trading halt expires 1st of June. Expect a statement from the company before this time.
      0
    • As expected. The Covid-19 test is now available via their US partner via Medicare and Mediaid.
      0
  • Commercial release of Covid19 risk test announced to be ready in US market before end of May.
    0
    • In the meantime - watch out for a coming spike when they launch their integration towards Medicare and Medicaid for their Covid-19 risk assessment test.
      0
      • If only GENE could make a gene-test that would tell if a patient will get an adverser reaction to the AstraZeneca vaccine towards Covid-19 - then they would have a winner!
        0
        • Finally - getting closer to the launch of Covid-19 Risk test in the US market. See announcement today
          0
          • Nice... :)
            0
            • Whats up?
              0
              • oversold
                0
            • seems like the market in general did not get the story about the distribution agreement for USA for the Covid-19 risk test.
              1
              • untill the next earning report day...
                0
            • There is good news on GENE's website!
              0
              • Trade is stopped by the company. News will coming...
                0
                • good or bad news?
                  0
                • Casa Albufeira The want  announce in relation to a material distribution agreement. So good news. See Link:https://hotcopper.com.au/threads/ann-trading-halt.5938772/
                  0
                • Pira Mahendran muito obrigado..
                  0